EGFR Status in Mesothelioma: Possible Implications for the Efficacy of Anti-Egfr and Anti-Met Therapies

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2016.03.001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Predicting Efficacy and Toxicity in the Era of Targeted Therapy: Focus on Anti-Egfr and Anti-Vegf Molecules

Current Drug Metabolism
Clinical BiochemistryPharmacology
2011English

Reply: KRAS Status Analysis and Anti-Egfr Therapies: Is Comprehensiveness a Biologist's Fancy or a Clinical Necessity?

British Journal of Cancer
Cancer ResearchOncology
2010English

HER2 Gene Copy Number Status May Influence Clinical Efficacy to Anti-Egfr Monoclonal Antibodies in Metastatic Colorectal Cancer Patients

British Journal of Cancer
Cancer ResearchOncology
2013English

Targeting Autophagy for Overcoming Resistance to Anti-Egfr Treatments

Cancers
Cancer ResearchOncology
2019English

MET-EGFR Dimerization in Lung Adenocarcinoma Is Dependent on EGFR Mtations and Altered by MET Kinase Inhibition

PLoS ONE
Multidisciplinary
2017English

EGFR Gene Copy Number Assessment From Areas With Highest EGFR Expression Predicts Response to Anti-Egfr Therapy in Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2011English

Targeted Delivery of 111In Into the Nuclei of EGFR Overexpressing Cells via Modular Nanotransporters With Anti-Egfr Affibody

Frontiers in Pharmacology
Pharmacology
2020English

Acquired Resistance Mechanisms to Combination Met-Tki/Egfr-Tki Exposure in Met-Amplified EGFR-TKI–Resistant Lung Adenocarcinoma Harboring an Activating EGFR Mutation

Molecular Cancer Therapeutics
Cancer ResearchOncology
2016English

Molecular Determinants of Anti-Egfr Sensitivity and Resistance in Metastatic Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy